| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/21/2011 | WO2011033361A3 Combination and composition that contains an antimicrobial, a glucocorticoid and an antimycotic |
| 07/21/2011 | WO2011032896A3 Encapsulation using wax-type substances |
| 07/21/2011 | WO2011031018A3 Water-soluble drug delivery system allowing slow release |
| 07/21/2011 | WO2011018800A3 In-situ gel forming solution for ocular drug delivery |
| 07/21/2011 | WO2011000811A4 Pharmaceutical solutions for infusion |
| 07/21/2011 | WO2010141879A3 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 07/21/2011 | WO2010100564A3 Injectable biomaterial |
| 07/21/2011 | WO2010069621A8 Treatment of vaginal atrophy in women with cardiovascular pathology risk |
| 07/21/2011 | WO2010029441A3 Nasal delivery |
| 07/21/2011 | WO2007117911A3 Novel formulations |
| 07/21/2011 | US20110178578 Piezoelectric transducer |
| 07/21/2011 | US20110178502 Cell therapy for limiting overzealous inflammatory reactions in tissue healing |
| 07/21/2011 | US20110178207 Particle-stabilised emulsions |
| 07/21/2011 | US20110178051 Topical skin care composition |
| 07/21/2011 | US20110178044 Transdermal administration of hydrophilic drugs using permeation enhancer composition |
| 07/21/2011 | US20110178006 Method for administering glp-1 molecules |
| 07/21/2011 | US20110177951 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof |
| 07/21/2011 | US20110177170 implantable neuroendoprosthetic system, a method of production thereof and a method of reconstructive neurosurgical operation |
| 07/21/2011 | US20110177169 Ophthalmic formulations of reversed liquid crystalline phase materials and methods of using |
| 07/21/2011 | US20110177168 Composition |
| 07/21/2011 | US20110177167 Hydrophilic/Lipophilic Polymeric Matrix Dosage Formulation |
| 07/21/2011 | US20110177166 Galenical Formulation Comprising Aliskiren and Process for its Preparation by Melt Extrusion Granulation |
| 07/21/2011 | US20110177165 Multiparticulate tablet and method for the production thereof |
| 07/21/2011 | US20110177164 Pharmaceutical Compositions Comprising Amorphous Esomeprazole, Dosage Forms And Process Thereof |
| 07/21/2011 | US20110177163 Compositions and methods for treating hepatitis a |
| 07/21/2011 | US20110177162 Degradable microcapsules |
| 07/21/2011 | US20110177161 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin |
| 07/21/2011 | US20110177160 Amino acid lipids and uses thereof |
| 07/21/2011 | US20110177159 Custom-formulated phospholipid microbubbles and methods and uses thereof |
| 07/21/2011 | US20110177158 Liposomes Capable of Effectively Binding the Beta Amyloid Peptide |
| 07/21/2011 | US20110177157 Compositions for Controlled Delivery of Pharmaceutically Active Compounds |
| 07/21/2011 | US20110177156 Sterol-Modified Amphiphilic Lipids |
| 07/21/2011 | US20110177155 Methods of delivery of agents to leukocytes and endothelial cells |
| 07/21/2011 | US20110177154 Tubular nanostructure targeted to cell membrane |
| 07/21/2011 | US20110177153 targeted nanoparticle drug for magnetic hyperthermia treatment on malignant tumors |
| 07/21/2011 | US20110177151 Implantable material and a method for the preparation thereof |
| 07/21/2011 | US20110177141 Microencapsulated delivery system |
| 07/21/2011 | US20110177139 Solid microstructure that enables multiple controlled release and method of maufacturing same |
| 07/21/2011 | US20110177138 Alcohol-resistant sustained-release oral pharmaceutical form based on microgranules |
| 07/21/2011 | US20110177137 Novel dosage form of paliperidone and process for preparing the same |
| 07/21/2011 | US20110177136 Method and product |
| 07/21/2011 | US20110177135 Methods of treating cartilage defects |
| 07/21/2011 | US20110177134 Viable Tissue Repair Implants and Methods of Use |
| 07/21/2011 | US20110177133 Use of opioid antagonists for treating urinary retention |
| 07/21/2011 | US20110177132 Compositions and Methods for Generating Musculoskeletal Tissue |
| 07/21/2011 | US20110177131 siRNA SILENCING OF FILOVIRUS GENE EXPRESSION |
| 07/21/2011 | US20110177130 Methods for preparation of lipid-encapsulated therapeutic agents |
| 07/21/2011 | US20110177068 Pharmaceutical preparation comprising an antibody against the egf receptor |
| 07/21/2011 | US20110177011 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of bruton's tyrosine kinase by such compounds |
| 07/21/2011 | US20110177010 Vitamin preparation |
| 07/21/2011 | US20110176997 Method to make porous materials and their applications |
| 07/21/2011 | US20110176994 Buoyant Polymer Particles for Delivery of Therapeutic Agents to the Central Nervous System |
| 07/21/2011 | US20110175245 Encapsulation |
| 07/21/2011 | US20110174653 Capsule with soluble blocking element |
| 07/21/2011 | US20110173928 Process to improve stability of a pharmaceutical composition |
| 07/21/2011 | CA2822220A1 Solid-forming local anesthetic formulations for pain control |
| 07/21/2011 | CA2792134A1 Heterocyclic carboxylic acid derivatives having a 2,5,7-substituted oxazolopyrimidine ring |
| 07/21/2011 | CA2787260A1 Methods and compositions for nanoparticle-mediated cancer cell-targeted delivery |
| 07/21/2011 | CA2787115A1 Flurane complex |
| 07/21/2011 | CA2786953A1 Pharmaceutical compositions for oral administration of insulin peptides |
| 07/21/2011 | CA2786671A1 Formulations of nano-carriers and methods of preparing the same |
| 07/21/2011 | CA2786181A1 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs |
| 07/21/2011 | CA2784287A1 Emulsion-based process for preparing microparticles and workhead assembly for use with same |
| 07/20/2011 | EP2345721A1 Recombinant gelatin in vaccines |
| 07/20/2011 | EP2345650A1 Amorphous (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole as anti-ulcer agent |
| 07/20/2011 | EP2345427A1 Fluoran complex |
| 07/20/2011 | EP2345426A1 Composite organic compound powder for medical use, method for producing same and suspension of same |
| 07/20/2011 | EP2345419A1 Mucosal vaccine using cationic nanogel |
| 07/20/2011 | EP2345415A1 Therapeutic/prophylactic agent for prostate cancer |
| 07/20/2011 | EP2345414A1 Tacrolimus preparation for external applications |
| 07/20/2011 | EP2345413A2 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin |
| 07/20/2011 | EP2345408A2 Acid labile drug formulations |
| 07/20/2011 | EP2345407A1 Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 07/20/2011 | EP2345406A1 Use of dimer diol in the production of bodily fluid substitutes |
| 07/20/2011 | EP2344519A2 C-terminal fragments of glucagon-like peptide-1 (glp-1) |
| 07/20/2011 | EP2344197A1 Lactose and cellulose-based tableting aid |
| 07/20/2011 | EP2344172A2 Herbal composition and method for the treatment of viral infection |
| 07/20/2011 | EP2344169A1 Silver ion delivery platform |
| 07/20/2011 | EP2344168A1 Anti-infective formulation and methods of use |
| 07/20/2011 | EP2344165A2 Pharmaceutical compositions comprising boronic acid compounds |
| 07/20/2011 | EP2344161A1 Combinations of a liposomal water-soluble camptothecin with cetuximab or bevacizumab |
| 07/20/2011 | EP2344155A2 Composition and method for treating dry eye syndrome |
| 07/20/2011 | EP2344151A2 Treatment and/or prevention of inner ear conditions by modulation of a metabotropic glutamate receptor |
| 07/20/2011 | EP2344141A2 Compositions comrrising amlodipine and bisoprolol |
| 07/20/2011 | EP2344140A2 A method for the production of bioadhesive compact matrices |
| 07/20/2011 | EP2344139A1 Method for delivering a pharmaceutical composition to patient in need thereof |
| 07/20/2011 | EP2344138A2 Use of polyether-based and vinyl monomer-based copolymers as binders for dosing forms comprising solid active ingredients |
| 07/20/2011 | EP2344137A1 Method for making cetirizine tablets |
| 07/20/2011 | EP2344136A1 Pharmaceutical dosage forms comprising poly(e-caprolactone) |
| 07/20/2011 | EP2344135A1 A process for making particles for delivery of drug nanoparticles |
| 07/20/2011 | EP2344134A2 Nanocarriers for drug delivery |
| 07/20/2011 | EP2344133A2 A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same |
| 07/20/2011 | EP2344132A2 Liposomal systems comprising sphingomyelin |
| 07/20/2011 | EP2344131A1 Decomposable biocompatible hydrogels and system and method for using same |
| 07/20/2011 | EP2344130A2 Pharmaceutical topical compositions |
| 07/20/2011 | EP2344129A1 Aerosol fluoroquinolone formulations for improved pharmacokinetics |
| 07/20/2011 | EP2344128A2 Ophthalmic administration of a composition including brimonidine as a mist |
| 07/20/2011 | EP2344127A1 Medical devices with definable porosity produced by bacterial polymer bio-synthesis |
| 07/20/2011 | EP2344126A1 Method for treatment of copd and other pulmonary diseases |
| 07/20/2011 | EP2344125A1 Implantable device for the delivery of histrelin and methods of use thereof |